Comparative Pharmacology
Head-to-head clinical analysis: TROPHAMINE versus TROPHAMINE 10.
Peer-Reviewed Evidence
Head-to-head clinical analysis: TROPHAMINE versus TROPHAMINE 10.
TROPHAMINE vs TROPHAMINE 10%
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
TROPHAMINE is a balanced amino acid injection that provides essential and non-essential amino acids for protein synthesis, tissue repair, and maintenance of nitrogen balance. It serves as a substrate for gluconeogenesis and stimulates insulin secretion.
Trophamine 10% is an amino acid solution that provides essential and non-essential amino acids for protein synthesis and nitrogen balance in patients unable to tolerate oral or enteral nutrition. It acts as a substrate for protein synthesis, thereby promoting tissue repair and maintenance.
Intravenous infusion: 500-1000 mL per day (providing 6-10 g of amino acids) administered at a rate not exceeding 250 mL per hour. Dosage based on protein and calorie requirements.
Intravenous infusion, 500 mL to 2 L per day, typically administered at a rate of 125-200 mL/hour. Dosage individualized based on protein and caloric requirements.
None Documented
None Documented
Terminal elimination half-life is 1.5-2 hours in adults; prolonged in renal impairment.
Not applicable; amino acids rapidly cleared from plasma with half-life of 10-30 minutes due to tissue uptake and metabolism
Primarily renal (80-90%) as unchanged drug; minor biliary/fecal excretion (5-10%).
Renal: 98% as amino acids and peptides; fecal: <2%
Category C
Category C
Parenteral Nutrition (Amino Acid Solution)
Parenteral Nutrition (Amino Acid Solution)